SBS - The best value in QMS software

MDR reporting and CAPA thoughts? Classifying Complaints on Risk

Jkc3usc12

Involved In Discussions
#1
System I am working with is classifying complaints on risk. If it is high risk and determine to report a CAPA is automatically initiated.

If a medwatch is received a 3500a is filled out no matter and again a CAPA is initiated.

MDR Reporting and CAPA have always been separate decisions for me in the past. I understand they can tie in together just not every time. Also reporting any medwatch received I have never done.

Thoughts?

Thanks
 
Last edited:
Elsmar Forum Sponsor

Marcelo

Inactive Registered Visitor
#2
Usually, reportability is not directly related to risk classification (as it was done before by the regulator), it's simply a decision - does the event fits the criteria? If so, it's reportable, if not, it's not reportable.

As you mention CAPA (which is something that in practice do not exist, because you do not co CA PA or PA CA, you do either PA or correction, which may escalate to CA), maybe the problem is exactly in this distinction (which is a common problem in the US because people are really into the CAPA thing).

Normally, things would be like this:

- Event occurred.
- Is it reportable? If so, report.
- Is correction or any other immediate action necessary? If so, implement.
- What is the root cause of the event?
- Depending on the root cause, a CA may be necessary to prevent recurrence. It may be the case that a CA is not required.
 

Jkc3usc12

Involved In Discussions
#3
A risk matrix for complaints is used to determine risk and which if coded high is reported. If reported a PA or CA is automatically initiated.

I feel the investigation of the root cause would be the determination of the PA or the CA if needed. Not just because it is high risk.

Also your thoughts on receiving a medwatch and automatically initiating a 3500 and another PA or CA.
 

Marcelo

Inactive Registered Visitor
#4
A risk matrix for complaints is used to determine risk and which if coded high is reported. If reported a PA or CA is automatically initiated.
A report has to be submitted (I'm using a manufacturer as an example) when the manufacturer "they learn that any of their devices may have caused or contributed to a death or serious injury. Manufacturers must also report to the FDA when they become aware that their device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction were to recur."

This has nothing to do with risk classification or analysis. It's either fir the trigger or not.

I feel the investigation of the root cause would be the determination of the PA or the CA if needed. Not just because it is high risk.
If the event already occurred, there can be no PA, as PA if before something happen. The investigation of the root cause (after any correction or other immediate action) would then be used to determine if a CA is required.
 

Jkc3usc12

Involved In Discussions
#5
I agree with you. The risk assessment is to help determine a potentially reportable incident. I just having a hard time saying that every reportable event leads to the capa process and also determining to report is based solely off the risk matrix. Not actually what happened.

I also have a hard time reporting when any medwatch is received which also then goes through the capa process.

I am in the process of trying to steer this away from the direction they are in.

Just seeing if my thoughts are off base?
 

Marcelo

Inactive Registered Visitor
#6
I agree with you. The risk assessment is to help determine a potentially reportable incident. I just having a hard time saying that every reportable event leads to the capa process and also determining to report is based solely off the risk matrix. Not actually what happened.

I also have a hard time reporting when any medwatch is received which also then goes through the capa process.

I am in the process of trying to steer this away from the direction they are in.

Just seeing if my thoughts are off base?
I think you are in the right path.

As I mention before, the problem seems to be in the concept of CAPA. A lot of people thinks that a CA is always required when a problem is found, which is not true. ISO 13485 makes it more clear, because the text in the CFR is misleading.

An correction or other immediate action is required after an NC is detected (see 8.3.2 of ISO 13485).

After that, you need to evaluate the root cause of the NC/complaint (8.5.2 b) of ISO 13485).

Then you need to device if there's a need to escalate to a CA or not (8.5.2 c) of ISO 13485).
 

Jkc3usc12

Involved In Discussions
#7
Yes those steps make sense.

You agree that there can be MDR reporting without CA?

The view of risk dictates everything so one cant go without the other. high risk report and capa. Low risk nether.
 

Jkc3usc12

Involved In Discussions
#9
They view of risk dictates everything so one cant go without the other. high risk report and capa. Low risk nether.

So there is no possible MDR reporting without a CAPA being issued. Its ether both or nether. If the complaint is deemed high risk its reported and a capa.

Same thing with a medwatch received will automatically be reported and a CAPA issued.
 

Marcelo

Inactive Registered Visitor
#10
They view of risk dictates everything so one cant go without the other. high risk report and capa. Low risk nether.

So there is no possible MDR reporting without a CAPA being issued. Its ether both or nether. If the complaint is deemed high risk its reported and a capa.

Same thing with a medwatch received will automatically be reported and a CAPA issued.
Yes, I understood what you said, but to do it this way does not make any sense.
 
Thread starter Similar threads Forum Replies Date
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
T Trend Reporting under the EU MDR EU Medical Device Regulations 12
L MDR (Medical Device Reporting) under 21 CFR Part 803 Other US Medical Device Regulations 5
B Is there a MDR (Medical Device Reporting) equivalent in China ? China Medical Device Regulations 1
C New draft MDR reporting guidance Other US Medical Device Regulations 1
R MDR Reporting for event with RUO instrument 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
S MDR (Medical Device Reporting) Justification - Canned Statements Other US Medical Device Regulations 2
E Post Inspection Regulatory Action by US FDA - 21 CFR 803 - MDR Reporting Other US Medical Device Regulations 4
E Reporting Requirements - Report to US FDA if a MDR event happened outside US Other US Medical Device Regulations 3
L Interpretation of MDR Reportable Event - FDA guidance on Medical Device Reporting 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 16
W MDR Reporting - How to interpret requirements for MDR Other US Medical Device Regulations 14
Q When to File an MDR (Medical Device Reporting) For Incidents in Foreign Countries 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
Ed Panek Upcoming NB MDD ---> MDR Crunch EU Medical Device Regulations 0
S MDR - System and procedure pack article 22 and all sub processes that apply ISO 13485:2016 - Medical Device Quality Management Systems 0
C Requirements for distributors under MDR: translation EU Medical Device Regulations 0
A Should we assign the PRRC before the date of application of MDR (26 May 2021)? EU Medical Device Regulations 0
N Looking for a recommendation for an EU MDR Importer EU Medical Device Regulations 1
JoCam Rental and MDD versus MDR EU Medical Device Regulations 1
A Can anyone share a Distribution Agreement template under MDR 2017/745? EU Medical Device Regulations 0
A MDR ANNEX XI part A or Part B EU Medical Device Regulations 0
N OBL under the MDR. Which are the obligations of the OEM? EU Medical Device Regulations 0
U Distributor obligations under MDR EU Medical Device Regulations 3
Raisin picker CECP, consultation according to Art 54 MDR EU Medical Device Regulations 1
K Question on MDR classification EU Medical Device Regulations 4
M STED vs MDR EU Medical Device Regulations 0
F UDI-PI required on packaging (MDR) EU Medical Device Regulations 2
M Extension to shelf life of new product under MDR EU Medical Device Regulations 1
J Instructions for use for Class I devices under MDR EU Medical Device Regulations 1
K Importer in EU, but not distribute in the EU - MDR obligations EU Medical Device Regulations 0
K MDR Class 1 Self Certification - Competent Authority or Notified Body? EU Medical Device Regulations 6
M Responsibilities of Importers / Distributors - MDR EU Medical Device Regulations 3
S PSUR - MDR First Submission Requirement? EU Medical Device Regulations 2
R EU-MDR Article 9-common specifications Other ISO and International Standards and European Regulations 2
JoCam Certified QMS for MDR - Class I medical device manufacturers EU Medical Device Regulations 4
JoCam MDR Gap Analysis - Consultant fees EU Medical Device Regulations 10
N Is there a need for clinical test of Class IIa products (for MDR)? EU Medical Device Regulations 2
M Examples of Combination Products - MDR Article 1 (8) and MDR Article 1(9) Medical Device and FDA Regulations and Standards News 3
P EU MDR Translation of Product Name EU Medical Device Regulations 1
N Is this a single integral drug device combination product EU MDR CE Marking (Conformité Européene) / CB Scheme 1
R Components to a finished medical device, MDR requirements Other US Medical Device Regulations 1
K Quality Agreement MDR - The manufacturer is outside of EU Other Medical Device Related Standards 4
M MDR - eIFU - When you can supply an electronic IFU instead of a paper IFU EU Medical Device Regulations 5
M MDR harmonized standards EU Medical Device Regulations 3
cscalise RAPS/Med Dev EU MDR Guidebook - Reviews or Opinions? EU Medical Device Regulations 4
V New Product Model CE Mark Certification under MDR EU Medical Device Regulations 0
E MDR PRRC "jointly responsible" EU Medical Device Regulations 1
J Strategy for MDR Regulatory Compliance Procedure ISO 13485:2016 - Medical Device Quality Management Systems 4
S EU MDR Annex I Chapter III 23.4 z EU Medical Device Regulations 2
R MDR & depth of technical files review by NB's EU Medical Device Regulations 18
U EU-MDR: Complicated supply chain EU Medical Device Regulations 4

Similar threads

Top Bottom